Agreement focuses on rimiducid, an agent used to activate certain “safety switch” cell elimination technologies in cell and gene therapies...
Read More
Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by...
Read More
